BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28777892)

  • 1. Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis.
    Nehmar R; Alsaleh G; Voisin B; Flacher V; Mariotte A; Saferding V; Puchner A; Niederreiter B; Vandamme T; Schabbauer G; Kastner P; Chan S; Kirstetter P; Holcmann M; Mueller C; Sibilia J; Bahram S; Blüml S; Georgel P
    Arthritis Rheumatol; 2017 Nov; 69(11):2124-2135. PubMed ID: 28777892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel Toll-like Receptor 7 Endogenous Ligand in Rheumatoid Arthritis Synovial Fluid That Can Provoke Arthritic Joint Inflammation.
    Kim SJ; Chen Z; Essani AB; Elshabrawy HA; Volin MV; Volkov S; Swedler W; Arami S; Sweiss N; Shahrara S
    Arthritis Rheumatol; 2016 May; 68(5):1099-110. PubMed ID: 26662519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
    Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
    Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
    Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
    Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
    Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
    J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.
    Drobits B; Holcmann M; Amberg N; Swiecki M; Grundtner R; Hammer M; Colonna M; Sibilia M
    J Clin Invest; 2012 Feb; 122(2):575-85. PubMed ID: 22251703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
    Rajagopal D; Paturel C; Morel Y; Uematsu S; Akira S; Diebold SS
    Blood; 2010 Mar; 115(10):1949-57. PubMed ID: 20065291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice.
    Marietta EV; Murray JA; Luckey DH; Jeraldo PR; Lamba A; Patel R; Luthra HS; Mangalam A; Taneja V
    Arthritis Rheumatol; 2016 Dec; 68(12):2878-2888. PubMed ID: 27337150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis.
    Louis C; Ngo D; D'Silva DB; Hansen J; Phillipson L; Jousset H; Novello P; Segal D; Lawlor KE; Burns CJ; Wicks IP
    Arthritis Rheumatol; 2019 Jan; 71(1):50-62. PubMed ID: 30009417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights.
    Zhou Q; Vadakekolathu J; Watad A; Sharif K; Russell T; Rowe H; Khan A; Millner PA; Loughenbury P; Rao A; Dunsmuir R; Timothy J; Damiani G; Pigatto PDM; Malagoli P; Banfi G; El-Sherbiny YM; Bridgewood C; McGonagle D
    Front Immunol; 2021; 12():635018. PubMed ID: 33936047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
    Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
    Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
    Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
    Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
    Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spi-B is critical for plasmacytoid dendritic cell function and development.
    Sasaki I; Hoshino K; Sugiyama T; Yamazaki C; Yano T; Iizuka A; Hemmi H; Tanaka T; Saito M; Sugiyama M; Fukuda Y; Ohta T; Sato K; Ainai A; Suzuki T; Hasegawa H; Toyama-Sorimachi N; Kohara H; Nagasawa T; Kaisho T
    Blood; 2012 Dec; 120(24):4733-43. PubMed ID: 23065153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons.
    Gregorio J; Meller S; Conrad C; Di Nardo A; Homey B; Lauerma A; Arai N; Gallo RL; Digiovanni J; Gilliet M
    J Exp Med; 2010 Dec; 207(13):2921-30. PubMed ID: 21115688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
    Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Fujimoto C; Kataoka S; Terada Y; Sano S
    Arthritis Rheumatol; 2014 Mar; 66(3):694-706. PubMed ID: 24574230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.
    Athari SK; Poirier E; Biton J; Semerano L; Hervé R; Raffaillac A; Lemeiter D; Herbelin A; Girard JP; Caux F; Boissier MC; Bessis N
    Arthritis Res Ther; 2016 Jun; 18(1):143. PubMed ID: 27317338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type I IFN system in rheumatoid arthritis.
    Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G
    Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
    J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.